Does RITUXIMAB-PVVR Cause Poor venous access? 55 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Poor venous access have been filed in association with RITUXIMAB-PVVR. This represents 1.3% of all adverse event reports for RITUXIMAB-PVVR.
55
Reports of Poor venous access with RITUXIMAB-PVVR
1.3%
of all RITUXIMAB-PVVR reports
5
Deaths
20
Hospitalizations
How Dangerous Is Poor venous access From RITUXIMAB-PVVR?
Of the 55 reports, 5 (9.1%) resulted in death, 20 (36.4%) required hospitalization, and 1 (1.8%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-PVVR. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-PVVR Cause?
Off label use (2,079)
Intentional product use issue (627)
Condition aggravated (514)
Death (338)
Covid-19 (322)
Fatigue (318)
Dyspnoea (314)
Inappropriate schedule of product administration (311)
Headache (291)
Pruritus (288)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which RITUXIMAB-PVVR Alternatives Have Lower Poor venous access Risk?
RITUXIMAB-PVVR vs RIVAROXABAN
RITUXIMAB-PVVR vs RIVASTIGMINE
RITUXIMAB-PVVR vs RIVOTRIL
RITUXIMAB-PVVR vs RIZATRIPTAN
RITUXIMAB-PVVR vs ROACTEMRA